Hinge Health, Inc. (NYSE: HNGE) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $9.3B. The Maz Rating grades it against the other companies in its sector.
Hinge Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $114.74, Hinge Health, Inc. trades at 58.3x trailing earnings, 12.3x sales and 32.8x book value, with an EV/EBITDA of 58.9. Over the last twelve months it generated about $758M of revenue and $160M of net income. It runs a gross margin of 85.7%, an operating margin of 18.7% and a net margin of 21.0%. It shows return on equity of 50.5%, return on invested capital of 44.9% and a free cash flow yield of 3.2%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 1.04. Over the past 52 weeks the share price ranged from $30.08 to $126.40, with a beta of 1.36.
Hinge Health, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 16 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Hinge Health, Inc. (HNGE) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 4.41% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.67% / 33% · Receivables / Mkt Cap (36m) 1.85% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.67% / 33.33% · Receivables / Mkt Cap (24m) 1.85% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 43.0% / 33.33% · Receivables / Avg Assets (4Q) 14.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 33.7% / 33.33% · (Cash+Recv) / Total Assets 50.7% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Hinge Health, Inc. (HNGE) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Hinge Health, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Hinge Health, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.